📰 Nasdaq Cyth News
Nasdaq Cyth News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Cyth. Real-time updates on events, politics, business and more.
May 5, 2024
HC Wainwright assumed coverage on shares of Cyclo Therapeutics (NASDAQ:CYTH – Free Report) in a research report sent to investors on Wednesday morning, Marketbeat reports. The firm issued a buy rating and a $3.00 target price on the stock. HC Wainwright also issued estimates for Cyclo Therapeutics’ Q1 2024 earnings at ($0.20) EPS, Q2 2024 […]
May 5, 2024
HC Wainwright began coverage on shares of Cyclo Therapeutics (NASDAQ:CYTH – Free Report) in a research note published on Wednesday, Marketbeat Ratings reports. The firm issued a buy rating and a $3.00 price target on the stock. HC Wainwright also issued estimates for Cyclo Therapeutics’ Q1 2024 earnings at ($0.20) EPS, Q2 2024 earnings at […]
April 12, 2024
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 45,600 shares, a decrease of 59.5% from the March 15th total of 112,600 shares. Approximately 0.4% of the shares of the company are […]
March 13, 2024
Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) and Revolution Medicines (NASDAQ:RVMD – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership. Profitability This table compares Cyclo Therapeutics and Revolution […]
February 4, 2024
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report)’s stock price fell 1.1% during mid-day trading on Friday . The stock traded as low as $1.81 and last traded at $1.88. 26,821 shares changed hands during trading, a decline of 76% from the average session volume of 111,431 shares. The stock had previously closed at $1.90. […]
January 12, 2024
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 331,200 shares, an increase of 83.3% from the December 15th total of 180,700 shares. Currently, 3.1% of the company’s stock are short sold. […]
November 29, 2023
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) saw a large increase in short interest in November. As of November 15th, there was short interest totalling 223,000 shares, an increase of 76.4% from the October 31st total of 126,400 shares. Currently, 2.6% of the company’s shares are sold short. Based on an average daily trading […]
October 1, 2023
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totalling 133,100 shares, a decrease of 31.3% from the August 31st total of 193,800 shares. Based on an average daily volume of 56,400 shares, the short-interest ratio […]
August 26, 2023
Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) and Axcella Health (NASDAQ:AXLA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, risk, earnings and valuation. Earnings & Valuation This table compares Cyclo […]
July 30, 2023
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a large increase in short interest in the month of July. As of July 15th, there was short interest totalling 94,400 shares, an increase of 93.8% from the June 30th total of 48,700 shares. Based on an average daily trading volume, of 153,200 […]